Improve Medical Instruments' (SHE:300030) unit, Guangzhou Yangpu Medical Device, obtained a medical device registration certificate for its disposable retractable venous blood collection needle, according to a Shenzhen bourse filing on Thursday.
The medical device maker's shares slipped by less than 1% at the close of Friday's trade.
The certificate is valid from May 22, 2026, to May 21, 2031.
Hon Hai Precision Industry (TPE:2317), also known as Foxconn, will start shipping co-packaged optics (CPO) switch trays for AI infrastructure this year, targeting about 10,000 units and more than doubling volumes by 2027, Nikkei Asia reported Friday, citing Chairman Young Liu.Liu said demand for faster data transmission is rising sharply alongside growing AI computing power, driving strong uptake for next-generation optical technologies used in data centers, according to the report.The technology, developed in collaboration with key industry players including Nvidia, is being produced at Foxconn's Vietnam facility, with shipments expected to begin from the third quarter as the firm expands its AI server footprint, the news outlet said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
S&P Global Ratings maintained Nippon Steel's (TYO:5401) BBB long-term issuer credit rating, according to a recent release.The rating agency expects the company's key financial metrics to improve more gradually than previous estimates given a weak Japanese steel segment and further capital expenditure.The company took measures to raise profitability and lessen fixed costs, but it still faces a dampened domestic steel market and stagnation in Asian markets where it primarily exports, the rating agency said.Heavy investments will also result in a free operating cash flow deficit of between 200 billion yen and 300 billion yen as well as only a slight recovery in the debt-to-EBITDA ratio to about 3.9x in fiscal 2026, according to S&P.The metrics could recover in the next year or so, but S&P sees volatile business conditions as a risk.The negative outlook considers S&P's belief that the rebound in the major financial ratios may not happen as expected if the debt burden becomes a main pressure point.Notable developments impacting the company's debt-to-EBITDA ratio could prompt future rating actions, the rating agency said.
Siemens (NSE:SIEMENS, BOM:500550) has an average rating of overweight and mean price target of 3,510.70 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)